Sri Bioremedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-05-2024
- Paid Up Capital ₹ 8.55 M
as on 29-05-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 17.65 Cr
as on 29-05-2024
- Revenue 39.00%
(FY 2020)
- Profit 36.06%
(FY 2020)
- Ebitda 27.58%
(FY 2020)
- Net Worth 1.09%
(FY 2020)
- Total Assets 0.75%
(FY 2020)
About Sri Bioremedies
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.55 M.
The company has closed loans amounting to ₹17.65 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Venkata Kallam, Ramireddy Kallam, and Rama Reddy serve as directors at the Company.
- CIN/LLPIN
U01110TG1997PTC026890
- Company No.
026890
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Bioremedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Reddy  | Director | 15-Apr-1997 | Current |
| Venkata Kallam | Director | 21-Jul-2004 | Current |
| Ramireddy Kallam | Director | 21-Jul-2004 | Current |
Financial Performance and Corporate Structure Insights of Sri Bioremedies.
Sri Bioremedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 39% increase. The company also saw a substantial improvement in profitability, with a 36.06% increase in profit. The company's net worth moved up by a moderate rise of 1.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Bioremedies?
In 2017, Sri Bioremedies had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Biosphere Private LimitedActive 9 years 9 monthsRamireddy Kallam and Rama Reddy are mutual person
- Sri Lakshmi Agri Biotech Private LimitedActive 21 years 5 months
Ramireddy Kallam is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 20 Jun 2013 | ₹13.00 Cr | Satisfied |
The Ratnakar Bank Limited Creation Date: 21 Dec 2011 | ₹4.00 Cr | Satisfied |
Allahabad Bank Creation Date: 07 Dec 2006 | ₹6.00 M | Satisfied |
How Many Employees Work at Sri Bioremedies?
Sri Bioremedies has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Bioremedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
